Biotech

German biotech Kupando raises €10M more to take its innate immunity drug into the clinic

German biotech Kupando has raised €10M to advance its innate immunity drug KUP101 into human clinical trials, targeting solid tumors and drug-resistant infections.

Mar 1819

biotechExplainerbeginner

Tropic raises $105M to scale gene-edited bananas

Learn how gene editing technology, especially CRISPR, is being used to save bananas from a deadly disease and protect global food security.

Mar 1225